Bretaris Genuair

Bretaris Genuair is an inhalation medication containing Aclidinium Bromide, used for managing respiratory conditions. This bronchodilator helps improve airflow in the lungs, offering relief for those with chronic breathing difficulties.

Bretaris Genuair is primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It works by relaxing the muscles in the airways, making it easier to breathe. This medication is designed for long-term use and is not intended for immediate relief of sudden breathing problems.

Common effects of Bretaris Genuair may include dry mouth, throat irritation, and coughing. Some users might experience headaches or dizziness. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.

Bretaris Genuair should be used as directed by a healthcare professional. It is important to follow the prescribed dosage and administration instructions. Patients with certain medical conditions, such as heart problems or glaucoma, should inform their healthcare provider before using this medication.

Bretaris Genuair may interact with other medications, including beta-blockers and anticholinergics. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with your healthcare provider.